Validated stability-indicating derivative and derivative ratio methods for the determination of some drugs used to alleviate respiratory tract disorders and their degradation products

Drug Testing and Analysis

Volumn 3, Issue 5, 2011, Pages 306-318

  Hassib, Sonia T ^a   El Zaher, Asmaa A ^a   Fouad, Marwa A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Degradation products; Derivative ratio spectrophotometry; Derivative spectrophotometry; Respiratory tract drugs; Stability indicating methods.

Indexed keywords

BUTYRIC ACID; DEGRADATION; INDIUM COMPOUNDS; ISOMERS; PLANTS (BOTANY); SPECTROPHOTOMETRY;

DEGRADATION PRODUCTS; DERIVATIVE RATIO SPECTROPHOTOMETRY; DERIVATIVE RATIOS; DERIVATIVE SPECTROPHOTOMETRY; FORMOTEROL FUMARATE; RATIO METHOD; RESPIRATORY TRACT; RESPIRATORY TRACT DRUG; STABILITY INDICATING METHOD; STABILITY INDICATING METHOD.;

SODIUM;

BUTAMIRATE CITRATE; BUTYRIC ACID; CLEAR AIR; CROMOGLYCATE DISODIUM; FORMOTEROL FUMARATE; MONTELUKAST; UNCLASSIFIED DRUG;

ARTICLE; CIS ISOMER; DRUG DEGRADATION; DRUG DOSAGE FORM; PHOTODEGRADATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 79956207090     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.258     Document Type: Article

References (42)

1. J. L McGuire, Pharmaceuticals, Classes, Therapeutic Agents, Areas of Application, Respiratory tract, Wiley-Vch: New York, 2000, pp. 837-900.
2. A Korolkovas, Respiratory tract drugs, in Essentials of Medicinal Chemistry, 2nd Edn, John Wiley & Sons: Chichester, UK, 1988, pp. 329-334.
3. Kathleen Parfitt, Martindale: The Complete Drug Reference, 35th Edn, The Pharmaceutical Press: London, 2007, pp. 1400, pp. 1007-1008, pp. 1010-1011, pp. 1019-1021.
4. The Merck Index, 14th Edn, Merck and Co Inc: White House Station, NJ, 2006.
5. I Doi, C Altesor, M Knochen. Application of an optical compensation method to the simultaneous determination of butamirate citrate and sodium benzoate by derivative spectrophotometry in the ultraviolet. Quimica Analitica, 1996, 15(2), 148.
6. E. T Malliou, C. G Antoniou, J. E Koundourellis. Determination of butamyrate citrate in cough preparations by derivative UV spectrophotometry and high performance liquid chromatography. Anal. Sci. 2003, 19(4), 563.
7. B Koppenhoefer, A Jakob, X. F Zhu, B. C Lin. Separation of enantiomers of drugs by capillary electrophoresis with permethyl-gamma-cyclodextrin as chiral solvating agent. J. High Res. Chromatog. 2000, 23(6), 413.
8. The European Pharmacopoeia (EuP), 5th Edn. The Council of Europe, 2004. The Stationery Office on behalf of The Medicines and Healthcare Products Regulatory Agency: London, UK, 2007, pp. 924-926, pp. 2912-2913.
9. A. V. S. S Prasad. Simultaneous spectrophotometric determination of formoterol fumarate and budesonide in their combined dosage form. Indian J. Chem. Techn. 2006, 13(1), 81.
10. S. O Akapo, M Wegner, A Mamangun, C McCrea, M Asif, J. C Dussex. Optimization and validation of a gas chromatographic method for analysis of (RS, SR)-diastereoisomeric impurity in formoterol fumarate. J. Chromatogr. A 2004, 1045(1-2), 211.
11. S Akapo, C McCrea, J Gupta, M Roach, W Skinner. Chiral HPLC analysis of formoterol stereoisomers and thermodynamic study of their interconversion in aqueous pharmaceutical formulations. J. Pharmaceut. Biomed. 2009, 49(3), 632.
12. K. H Assi, W Tarsin, H Chrystyn. High performance liquid chromatography assay method for simultaneous quantitation of formoterol and budesonide in Symbicort Turbuhaler. J. Pharmaceut. Biomed. 2006, 41(1), 325.
13. 2-agonists in human or equine urine. J. Mass Spectrom. 2003, 38(11), 1197.
14. J. J Butter, B. T. J van den Berg, E. J. G Portier, G Kaiser, C. J van Boxtel. Determination by HPLC with electrochemical detection of formoterol RR and SS enantiomers in urine. J. Liq. Chromatogr. R. T. 1996, 19(6), 993.
15. J. Z Song, J Chen, S. J Tian, Z. P Sun. Assay for the determination of low dosage form of formoterol dry syrup by capillary electrophoresis with head-column field-amplified sample stacking. J. Pharmaceut. Biomed. 1999, 21(3), 569.
16. D. C Apperley, R. K Harris, T Larsson, T Malmstrom. Quantitative nuclear magnetic resonance analysis of solid formoterol fumarate and its dehydrate. J. Pharm. Sci. 2003, 92(12), 2487.
17. S. O Akapo, M Asif, L. P Dey. Validation of a RP-HPLC method for the assay of formoterol and its related substances in formoterol fumarate dihydrate drug substance. J. Pharmaceut. Biomed. 2003, 33(5), 935.
18. J Tillman, D. W Whymark. A method for the determination of disodium cromoglycate and other chromones. Analyst 1971, 96(1147), 689.
19. V Kocic-Pesic, D Radulovic, D Pecanac, L Zivanovic. Determination of sodium cromoglycate in pharmaceutical dosage forms using TLC-densitometry. Farmaco 1992, 47(12), 1563.
20. L. L Ng. Reversed-phase liquid-chromatographic determination of cromolyn sodium in drug substance and select dosage forms. J. AOAC Int. 1994, 77(6), 1689.
21. F. C Pereira, A. G Fogg, M. V. B Zanoni. Regeneration of poly-L-lysine modified carbon electrodes in the accumulation and cathodic stripping voltammetric determination of the cromoglycate anion. Talanta 2003, 60(5), 1023.
22. R. M Duhaime, L. K Rollins, D. J. K Gorecki, E. G Lovering. Liquid chromatographic determination of cromolyn sodium and related compounds in raw materials. J. AOAC Int. 1994, 77(6), 1439.
23. R Mansfield, J Huang, S Thatcher, R. B Miller, C. W Davis. Development and validation of a stability-indicating HPLC method for the determination of cromolyn sodium and its related substances in cromolyn sodium drug substance and cromolyn sodium inhalation solution. J. Liq. Chromatogr. R. T. 1999, 22(14), 2187.
24. M Barnes, R Mansfield, S Thatcher. The selection of an ion pairing reagent for developing and validating a stability-indicating HPLC method for cromolyn sodium and its known impurities. J. Liq. Chromatogr. R. T. 2002, 25(12), 1721.
25. M. S Ali, S Rafiuddin, D. A Al-Jawi, Y Al-Hetari, M. U. H Ghori, A. R Khatri. Stability-indicating assay of sodium cromoglicate in ophthalmic solution using mixed-mode hydrophilic interaction chromatography. J. Sep. Sci., 2008, 31, 1645.
26. T Radhakrishna, A Narasaraju, M Ramakrishna, A Satyanarayana. Simultaneous determination of montelukast and loratadine by HPLC and derivative spectrophotometric methods. J. Pharmaceut. Biomed. 2003, 31(2), 359.
27. I Alsarra, N. Y Khalil, M Sultan, R Al-Ashban, F Bela. Spectrofluorometric determination of Montelukast in dosage forms and spiked human plasma. Pharmazie 2005, 60(11), 823.
28. P Radhakrishnanand, D. V Subba Rao, K. V Surendranath, D Subrahmanyam, V Himabindu. A validated LC method for determination of the enantiomeric purity of montelukast sodium in bulk drug samples and pharmaceutical dosage forms. Chromatographia 2008, 68(3/4), 263.
29. I. A Alsarra. Development of a stability-indicating HPLC method for the determination of montelukast in tablets and human plasma and its applications to pharmacokinetic and stability studies. Saudi Pharm. J. 2004, 12(4), 136.
30. L Liu, H Cheng, J. J Zhao, J. D Rogers. Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching. J. Pharmaceut. Biomed. 1997, 15(5), 631.
31. C. J Kitchen, A. Q Wang, D. G Musson, A. Y Yang, A. L. J Fisher. A semi-automated 96-well protein precipitation method for the determination of montelukast in human plasma using high performance liquid chromatography/fluorescence detection. J. Pharmaceut. Biomed. 2003, 31(4), 647.
32. A Schonberg, A Sina. Khellin and allied compounds. J. Am. Chem. Soc. 1950, 72, 1611.
33. E. Spath, W. Gruber, Die constitution des khellins (aus Amni visnaga) (I. Mitteil. Über natürliche chromone), Berichte, 1938, 71B, pp 106-113.
34. M. M Al Omari, R. M Zoubi, E. I Hasan, T. Z Khader, A. A Badwan. Effect of light and heat on the stability of montelukast in solution and in its solid state. J. Pharmaceut. Biomed. 2007, 45(3), 465.
35. M Blanco, J Gene, H Iturriaga, S Maspoch, J Riba. Diode-array detectors in flow-injection analysis mixture resolution by multi-wavelength analysis. Talanta 1987, 34(12), 987.
36. F Salinas, J. J Berzas Nevado, M. A Espinosa. A new spectrophotometric method for quantitative multicomponent analysis resolution of mixtures of salicylic and salicyluric acids. Talanta 1990, 37(3), 347.
37. A El-Gindy. High performance liquid chromatographic determination of oxeladin citrate and oxybutynin hydrochloride and their degradation products. Farmaco 2005, 60(8), 689.
38. H Sedaira. Simultaneous determination of manganese and zinc in mixtures using first- and second-derivative spectrophotometry. Talanta, 2000, 51, 39.
39. B Morelli. Zero-crossing derivative spectrophotometry for the determination of mixtures of cephaloridine and cephalothin in pure and dosage forms. J. Pharm. Sci. 1988, 77(7), 615.
40. K. A Idriss, H sedaira, S. S Ahmed. Determination of strontium and simultaneous determination of strontium oxide, magnesium oxide and calcium oxide content of Portland cement by derivative ratio spectrophotometry. Talanta 2009, 78, 81.
41. E Dinc, D Baleanu. Application of the wavelet method for the simultaneous quantitative determination of benazepril and hydrochlorothiazide in their mixtures. J. AOAC Int. 2004, 87(4), 834.
42. ICH (International Conference on Harmonization), Guideline on Validation of Analytical Procedures: Text and Methodology, 2005, Q2 (R1).